Cargando…
Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
A meeting entitled ‘Current Perspective on the Use of Statins in the Treatment of Dyslipidemic Patients’ was held in Stresa, Italy, on 27–28th June 2019. The presentations covered the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines on dyslipidaemia, with d...
Autores principales: | Tokgözoglu, Lale, Zamorano, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295107/ https://www.ncbi.nlm.nih.gov/pubmed/32587627 http://dx.doi.org/10.7573/dic.2020-4-4 |
Ejemplares similares
-
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study
por: Casula, M., et al.
Publicado: (2020) -
Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013) -
Interaction Study on Garlic and Atorvastatin with Reference to Nephrotoxicity in Dyslipidaemic Rats
por: Reddy, G. Dilip, et al.
Publicado: (2010) -
Electrocardiographic abnormalities and dyslipidaemic syndrome in children with sickle cell anaemia
por: Adegoke, Samuel Ademola, et al.
Publicado: (2016) -
Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
por: Yokomichi, Hiroshi, et al.
Publicado: (2017)